Cutaneous toxicities secondary to STAT3 inhibition: A retrospective case series

JAAD Case Rep. 2025 Apr 17:61:136-142. doi: 10.1016/j.jdcr.2025.03.027. eCollection 2025 Jul.

Authors

Kevin P Lee¹, Apostolia M Tsimberidou², Abhijit Chakraborty², Anisha B Patel¹

Affiliations

¹ Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
² Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

No abstract available

Keywords: STAT3 inhibitor; cutaneous toxicity; immunotherapy toxicity; oncodermatology; signal transducer and activator of transcription protein.

Publication types

Case Reports